| __timestamp | GSK plc | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8246000000 | 59644696 |
| Thursday, January 1, 2015 | 9232000000 | 79541000 |
| Friday, January 1, 2016 | 9366000000 | 98015000 |
| Sunday, January 1, 2017 | 9672000000 | 103958000 |
| Monday, January 1, 2018 | 9915000000 | 103654000 |
| Tuesday, January 1, 2019 | 11402000000 | 128951000 |
| Wednesday, January 1, 2020 | 11456000000 | 135799000 |
| Friday, January 1, 2021 | 10975000000 | 149883000 |
| Saturday, January 1, 2022 | 8372000000 | 220206000 |
| Sunday, January 1, 2023 | 9385000000 | 265542000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of GSK plc and Travere Therapeutics, Inc. over the past decade. From 2014 to 2023, GSK plc's SG&A expenses have shown a steady increase, peaking in 2020 with a 39% rise from 2014. Meanwhile, Travere Therapeutics, Inc. has experienced a more dramatic growth, with expenses surging by over 345% during the same period. This stark contrast highlights the differing strategies and scales of these companies. GSK, a global giant, maintains a consistent expenditure pattern, while Travere, a smaller entity, reflects rapid expansion. Understanding these trends offers valuable insights into the financial strategies shaping the pharmaceutical industry today.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Zoetis Inc. and GSK plc
Comparing SG&A Expenses: GSK plc vs Dr. Reddy's Laboratories Limited Trends and Insights
GSK plc and Opthea Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of GSK plc and Apellis Pharmaceuticals, Inc.
Comparing SG&A Expenses: GSK plc vs Alkermes plc Trends and Insights
Cost Management Insights: SG&A Expenses for GSK plc and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: CRISPR Therapeutics AG vs Travere Therapeutics, Inc.
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or Travere Therapeutics, Inc.
Breaking Down SG&A Expenses: ImmunityBio, Inc. vs Travere Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Comparing SG&A Expenses: Agios Pharmaceuticals, Inc. vs Travere Therapeutics, Inc. Trends and Insights